[HTML][HTML] Evaluation of efficacy and safety of orlistat in obese patients
SS Jain, SJ Ramanand, JB Ramanand… - Indian journal of …, 2011 - journals.lww.com
… Present study was carried out to evaluate the efficacy and safety of orlistat in obese patients.
… to evaluate efficacy of orlistat along with its safety compared to placebo in obese patients. …
… to evaluate efficacy of orlistat along with its safety compared to placebo in obese patients. …
A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity
FX Pi-Sunyer - Clinical Therapeutics, 1996 - Elsevier
… to lower serum and urine uric acid levels in obese patients. 72,73 In a study reported by
Mancini et al,24 in which 71 severely obese patients were treated by very-low-calorie diets for 4 …
Mancini et al,24 in which 71 severely obese patients were treated by very-low-calorie diets for 4 …
Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery
AT Rocha, ÂG de Vasconcellos, ER da Luz Neto… - Obesity Surgery, 2006 - Springer
… obese patients.We review the evidence about obesity as a risk factor for VTE and about the
efficacy of prophylactic methods in hospitalized obese medical patients and obese patients …
efficacy of prophylactic methods in hospitalized obese medical patients and obese patients …
[HTML][HTML] Evaluation of efficacy, reliability, and tolerability of sibutramine in obese patients, with an echocardiographic study
A Halpern, CC Leite, N Herszkowicz… - Revista do Hospital …, 2002 - SciELO Brasil
… was to evaluate the efficacy, safety, and tolerability of sibutramine in obese patients over a
6-… drug on the echocardiographic patterns of the patients. We considered effective weight loss …
6-… drug on the echocardiographic patterns of the patients. We considered effective weight loss …
Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients
G Derosa, AFG Cicero, G Murdolo… - Diabetes, Obesity …, 2005 - Wiley Online Library
… in obese hypertensive patients, with a … : Patients were enrolled, evaluated and followed at
three Italian Centres of Internal Medicine. We evaluated 115 obese and hypertensive patients. (…
three Italian Centres of Internal Medicine. We evaluated 115 obese and hypertensive patients. (…
Anticoagulating obese patients in the modern era
… However, the data clearly shows that as weight increases, C max and AUC decreases and
again, although the change might be insignificant for obese patients, the efficacy of a fixed …
again, although the change might be insignificant for obese patients, the efficacy of a fixed …
Evaluating the safety and efficacy of BMI-based preoperative administration of low-molecular-weight heparin in morbidly obese patients undergoing Roux-en-Y gastric …
K Singh, ER Podolsky, S Um, S Saba, I Saeed… - Obesity Surgery, 2012 - Springer
… This review aims to assess both the efficacy and safety of varying doses of preoperative …
We conclude that BMI-based enoxaparin doses ranging from 30 to 60 mg are efficacious in …
We conclude that BMI-based enoxaparin doses ranging from 30 to 60 mg are efficacious in …
Is rimonabant efficacious and safe in the treatment of obesity? Evaluation of: Van Gaal L, Pi-Sunyer X, Deprés JP, et al. Efficacy and safety of rimonabant for …
SA Doggrell - Expert opinion on pharmacotherapy, 2008 - Taylor & Francis
… of obesity is increasing worldwide, and in the USA approximately 100 million adults are
overweight or obese. … Objectives/methods: This evaluation is of the Rimonabant in Obesity (RIO) …
overweight or obese. … Objectives/methods: This evaluation is of the Rimonabant in Obesity (RIO) …
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
… in non-diabetic overweight or obese patients. The aim of the RIO-Diabetes trial was to assess
the efficacy and safety of rimonabant in overweight or obese patients with type 2 diabetes …
the efficacy and safety of rimonabant in overweight or obese patients with type 2 diabetes …
Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients
C Kalani, E Awudi, T Alexander, G Udeani… - Hospital …, 2019 - Taylor & Francis
… (DOACs) in morbidly obese patients. We sought to examine the efficacy in preventing stroke
… in patients with either a body-mass index (BMI) over 40 kg/m2 and/or a weight over 120 kg. …
… in patients with either a body-mass index (BMI) over 40 kg/m2 and/or a weight over 120 kg. …
相关搜索
- morbidly obese patients
- direct oral anticoagulants obese patients
- efficacy and safety obese patients
- sibutramine in obese patients
- overweight obese patients
- bariatric surgery obese patients
- normotensive obese patients
- cardiovascular risk in obese patients
- comparative evaluation hypertensive obese patients
- type 2 diabetic obese patients
- extremely obese patients
- acute venous thromboembolism obese patients
- efficacy of thromboprophylaxis obese patients
- diabetic obese patients sibutramine treatment
- hypertensive obese patients sibutramine treatment